Bulletin
Investor Alert

New York Markets Close in:

Syneos Health Inc. Cl A

NAS: SYNH

GO
/marketstate/country/us

Countdown to close

 --Real time quotes

Jan 17, 2020, 3:08 p.m.

/zigman2/quotes/207981284/composite

$

63.85

Change

-0.0100 -0.02%

Volume

Volume 214,269

Real time quotes

/zigman2/quotes/207981284/composite

Previous close

$ 63.86

$ 63.85

Change

-0.0100 -0.02%

Day low

Day high

$63.32

$64.44

Open

52 week low

52 week high

$36.72

$64.73

Open

Annual Financials for Syneos Health Inc. Cl A

Fiscal year is January-December. All values USD millions. 20142015201620172018 5-year trend
Sales/Revenue 1.18B1.4B1.61B2.67B4.39B
Cost of Goods Sold (COGS) incl. D&A 938.67M1.08B1.27B2.23B3.71B
COGS excluding D&A 884.13M1.03B1.21B2.05B3.43B
Depreciation & Amortization Expense 54.54M56.01M59.2M179.94M273.69M
Depreciation 21.62M18.14M21.35M44.41M72.16M
Amortization of Intangibles 32.92M37.87M37.85M135.53M201.53M
Gross Income 240.13M316.32M344.5M440.88M682.12M
20142015201620172018 5-year trend
SG&A Expense 145.14M156.61M172.39M282.62M406.31M
Research & Development -----
Other SG&A 145.14M156.61M172.39M282.62M406.31M
Other Operating Expense -----
Unusual Expense 78.09M17.15M17.59M187.75M119.79M
EBIT after Unusual Expense 16.89M142.57M154.52M(29.49M)156.03M
Non Operating Income/Expense 7.69M3.86M(9M)(19.17M)29.07M
Non-Operating Interest Income 249,000192,000216,0001.18M3.69M
Equity in Affiliates (Pretax) -----
Interest Expense 53.04M15.64M11.62M64.41M131.53M
Gross Interest Expense 53.04M15.64M11.62M64.41M131.53M
Interest Capitalized -----
Pretax Income (28.2M)130.97M134.12M(111.88M)57.26M
Income Tax (4.73M)13.93M21.49M26.59M32.97M
Income Tax - Current Domestic 1.04M3.99M33.4M(5.87M)22.34M
Income Tax - Current Foreign 9.06M5.81M10.35M18.03M10.4M
Income Tax - Deferred Domestic (945,000)(180,000)(17.08M)14.74M2.62M
Income Tax - Deferred Foreign (13.89M)4.31M(5.18M)(312,000)(2.38M)
Income Tax Credits -----
Equity in Affiliates -----
Other After Tax Income (Expense) (3.75M)----
Consolidated Net Income (27.22M)117.05M112.63M(138.47M)24.28M
Minority Interest Expense -----
Net Income (27.22M)117.05M112.63M(138.47M)24.28M
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries (27.22M)117.05M112.63M(138.47M)24.28M
Preferred Dividends -----
Net Income Available to Common (27.22M)117.05M112.63M(138.47M)24.28M
EPS (Basic) (0.51)2.022.08(1.85)0.23
Basic Shares Outstanding 53.3M57.89M54.03M74.91M103.41M
EPS (Diluted) (0.51)1.952.03(1.85)0.23
Diluted Shares Outstanding 53.3M60.15M55.61M74.91M104.7M
EBITDA 149.53M215.73M231.32M338.2M549.5M
Link to MarketWatch's Slice.